New oral pill targets common Cancer-Causing mutations in major trial

NCT ID NCT05379985

Recruiting now Disease control Sponsor: Revolution Medicines, Inc. Source: ClinicalTrials.gov ↗

Summary

This study is testing a new oral medication called RMC-6236 in adults with advanced solid tumors that have specific mutations in a gene called RAS. The main goals are to find a safe and effective dose and to see if the drug can help control cancers like non-small cell lung cancer, colorectal cancer, and pancreatic cancer. Participants will take the drug continuously to try to shrink their tumors or stop them from growing.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Christ Hospital Cancer Center
RECRUITING

Cincinnati, Ohio, 45219, United States
Columbia University
RECRUITING

New York, New York, 10032, United States
Dana Farber Cancer Institute
RECRUITING

Boston, Massachusetts, 02215, United States
Huntsman Cancer Institute
RECRUITING

Salt Lake City, Utah, 84112, United States
Johns Hopkins University
RECRUITING

Baltimore, Maryland, 21287, United States
Mary Crowley Cancer Research
RECRUITING

Dallas, Texas, 75230, United States
Memorial Sloan-Kettering Cancer Center
RECRUITING

New York, New York, 10021, United States
Moffitt Cancer Center
RECRUITING

Tampa, Florida, 33612, United States
Next Oncology
RECRUITING

San Antonio, Texas, 78229, United States
Next Oncology Virginia
RECRUITING

Fairfax, Virginia, 22031, United States
Perlmutter Cancer Center at NYU Langone Health
RECRUITING

New York, New York, 10016, United States
Sarah Cannon Research Institute
RECRUITING

Nashville, Tennessee, 37203, United States
The University of Texas MD Anderson Cancer Center
RECRUITING

Houston, Texas, 77030, United States
UC Irvine/Chao Family Comprehensive Cancer Center
RECRUITING

Orange, California, 92868, United States
UCLA
RECRUITING

Santa Monica, California, 90404, United States
University of Texas at Austin
RECRUITING

Austin, Texas, 78712, United States

Conditions

Explore the condition pages connected to this study.

ADVANCED SOLID TUMORS COLORECTAL CANCER (CRC) NON-SMALL CELL LUNG CANCER (NSCLC) PANCREATIC DUCTAL ADENOCARCINOMA (PDAC)